Overview
Tests for solitary fibrous tumors depend on your symptoms and the tumor location. They may include:
- An eye exam, including optical coherence tomography (OCT) and visual field testing, to pinpoint the cause of vision problems.
- Imaging scans like X-rays, CT scans, MRIs, ultrasounds and PET scans to find tumors.
- A biopsy to determine the tumor type and whether it’s cancerous.
What are the World Health Organization (WHO) classifications of solitary fibrous tumors?
The WHO has a classification system for grading the severity of solitary fibrous tumors. A tumor grade indicates how fast or slow a tumor might grow based on how cells look under a microscope. It’s different from cancer stages, which refer to a cancer tumor’s location, size and spread (growth).
Tumor grades for solitary fibrous tumors range from I to III:
- Grade I (low-grade): Low-grade tumors have mostly normal-looking cells. These tumors are the least aggressive type. They tend to grow slowly and may not cause symptoms.
- Grade II (intermediate-grade): The cells in intermediate-grade tumors look more like abnormal cells than those in low-grade tumors. As a result, they’ll grow slightly faster than grade I tumors. They’re also more likely to become cancerous.
- Grade III (high-grade): High-grade tumors contain mostly abnormal-looking cells. These tumors are aggressive and grow fast. They’re also more likely to come back, become cancerous and spread to other parts of your body.
Symptoms
When to see a doctor
Complications
- High blood pressure.
- Diabetes.
- Heart failure.
- Some types of heart valve disease.
Prevention
- Control high blood pressure, high cholesterol and diabetes.
- Don't smoke or use tobacco.
- Eat a diet that's low in salt and saturated fat.
- Exercise at least 30 minutes a day on most days of the week unless your health care team says not to.
- Get good sleep. Adults should aim for 7 to 9 hours daily.
- Maintain a healthy weight.
- Reduce and manage stress.
Living with atrial fibrillation?
Heart Rhythm Conditions Discussions
Comments are closed for this post.